GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally. It offers Galleri, a cancer screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The company also provides development services, including support for ongoing clinical studies, pilot testing, research, and therapy development. In addition, it develops minimal residual disease post-diagnostic tests. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
तुलना करने के लिए मीट्रिक्स | GRAL | क्षेत्र सेक्टर - संबंधित क्षेत्र की कंपनियों के व्यापक समूह से मेट्रिक्स का औसत हेल्थकेयर | संबंध संबंधGRALपीअर्सक्षेत्र | |
|---|---|---|---|---|
पी/ई अनुपात | −10.5x | −3.3x | −0.6x | |
PEG अनुपात | −0.13 | −0.03 | 0.00 | |
क़ीमत/बुक | 1.9x | 3.3x | 2.6x | |
क़ीमत / एलटीएम बिक्री | 30.0x | 16.4x | 3.4x | |
अपसाइड (विश्लेषक लक्ष्य) | 0.9% | 8.0% | 42.5% | |
उचित मूल्य अपसाइड | अनलॉक करें | −30.5% | 5.0% | अनलॉक करें |